Search hospitals > Tennessee > Germantown
West Cancer Center
Claim this profileGermantown, Tennessee 38138
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
141 reported clinical trials
14 medical researchers
Summary
West Cancer Center is a medical facility located in Germantown, Tennessee. This center is recognized for care of Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Tumors and other specialties. West Cancer Center is involved with conducting 141 clinical trials across 106 conditions. There are 14 research doctors associated with this hospital, such as Noam A. VanderWalde, Daniel A Vaena, Lee Schwartzberg, MD, and Gregory Vidal, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
Stage III
2Cancer
Global LeaderStage IV
Stage III
TSC1 positive
Top PIs
Noam A. VanderWaldeThe West Clinic - Wolf River1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
7 reported clinical trials
18 drugs studied
Daniel A VaenaWest Cancer Center2 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
7 reported clinical trials
17 drugs studied
Lee Schwartzberg, MDRenown Regional Medical Centre1 year of reported clinical research
Studies Breast Cancer
Studies Chemotherapy Side Effects
6 reported clinical trials
10 drugs studied
Gregory Vidal, MDWest Cancer Center6 years of reported clinical research
Studies Breast Cancer
Studies Diarrhea
5 reported clinical trials
10 drugs studied
Clinical Trials running at West Cancer Center
Breast Cancer
Cancer
Colorectal Cancer
Bladder Cancer
Endometrial Cancer
Skin Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Liposarcoma
Transitional Cell Carcinoma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).
Recruiting4 awards Phase 3
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This study is evaluating whether a drug called giredestrant can improve the survival of women with early breast cancer.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at West Cancer Center?
West Cancer Center is a medical facility located in Germantown, Tennessee. This center is recognized for care of Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Tumors and other specialties. West Cancer Center is involved with conducting 141 clinical trials across 106 conditions. There are 14 research doctors associated with this hospital, such as Noam A. VanderWalde, Daniel A Vaena, Lee Schwartzberg, MD, and Gregory Vidal, MD.